Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

Company Overview - Viatris Inc. is a strong global and diverse company with operations in 165 countries, generating $15 billion in revenue over the last 12 months [3][4] - The company reported an adjusted EBITDA of$4.8 billion and free cash flow of $2.4 billion, indicating significant financial strength [3] Product Portfolio - Viatris is home to several iconic pharmaceutical brands, including Lipitor, Lyrica, Celebrex, Norvasc, and Viagra, which are key components of its business strategy [3] Conference Presentation - The presentation at the J.P. Morgan Healthcare Conference included a brief introduction by CEO Scott Smith, followed by a Q&A session with the management team [1][2] - The company will not provide guidance for the full year 2024 or for 2025 during this presentation [2]